Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
-based approach with antibody-based therapy in human B-NHL cell lines, primary DLBCL and CLL patient samples and lymphoma mouse models. This research will provide molecular and biological insight
-
stem cells and primary patient cells), and techniques (CRISPR gene editing, ATAC-, ChIP-, RNA-seq and label-free quantitative mass spec) will be used with the goal to gain a better insight in disease
-
of Paediatric Urology who is due to retire. For this challenging and inspiring position, we are looking for a professor or someone eligible for appointment as a professor of Paediatric Urology. The primary focus
-
vaccines in this model. Your main role is to facilitate knowledge generation by managing the link between researchers and stakeholders and your tasks will therefore include: Support in acquisition
-
Master degree in disciplines relevant for the position (e.g. biochemistry, tissue engineering, biotechnology, biomedical sciences, medical/human biology). Familiarity with biochemistry and related
-
are trained in radiation physics, radiation biology, radiation safety, or dosimetry. Further you recognize yourself in the profile below: Masters degree in (bio)physics, health physics, technical
-
, or dosimetry. Further you recognize yourself in the profile below: Masters degree in (bio)physics, health physics, technical medicine, clinical technology, or equivalent. Experience with Geant4 or other relevant
-
complaints and improvement of quality of life. Together with the German PhD-student, you will perform the proposed studies. You will be the main spokesperson for all partners involved in this project. You will
-
time in the world. These technical aspects must be combined and tested in phantoms, animal studies, and in case of positive results, also in patients. The combined techniques will be the main part of
-
in collaboration with Radboudumc, Universitätsklinikum Düsseldorf and Universitatsklinikum Münster. Neuro-oncological disease is subdivided into two subtypes: primary neuro-oncological diseases (e.g